Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DLE Adjuvant Therapy for Allergic Rhinoconjunctivitis
NCT02506998Phase 2Completed
- Sponsor
- Instituto Politécnico Nacional
- Start
- Aug 2013
- Primary completion
- Jan 2015
- Modality
- Peptides
01
Overview
A Phase 2 trial of Transferon in allergic rhinoconjunctivitis (ARC), sponsored by Instituto Politécnico Nacional. Started Aug 2013; status: completed.
02
Drugs
Transferon
03
Conditions
allergic rhinoconjunctivitis (ARC)
Beyond the preview
Go deeper on NCT02506998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02506998.